Philippines - English - FDA (Food And Drug Administration)

zuellig pharma corporation; distributor: zuellig pharma corporation - recombinant human insulin (70% isophane/30% soluble) - suspension for injection (sc) - 100 iu/ml

Philippines - English - FDA (Food And Drug Administration)

eli lilly phils inc - recombinant human insulin (70% isophane / 30% soluble) - suspension for injection f(sc) - 100 iu/ml

New Zealand - English - Medsafe (Medicines Safety Authority)

eli lilly and company (nz) limited - insulin, human, recombinant dna origin 100 [iu] (as 70% isophane insulin and 30% regular insulin) - suspension for injection - 100 iu/ml - active: insulin, human, recombinant dna origin 100 [iu] (as 70% isophane insulin and 30% regular insulin) excipient: dibasic sodium phosphate heptahydrate glycerol hydrochloric acid as 10% solution for ph adjustment metacresol phenol protamine sulfate sodium hydroxide as 10% solution for ph adjustment water for injection zinc oxide - humulin is indicated for the treatment of insulin-requiring diabetes mellitus

Philippines - English - FDA (Food And Drug Administration)

zuellig pharma corp.; distributor: zuellig pharma corp. - isophane insulin human (recombinant dna) 70% isophane insulin , 30% soluble insulin - suspension for injection (s.c.) - 100 units/ml

Uganda - English - National Drug Authority

bioton s.a. - insulin human of recombinant dna origin (30% soluble insulin + 70% isophane insulin) - parenteral ordinary s c vials - 100 iu/ml

Philippines - English - FDA (Food And Drug Administration)

getz pharma phils., inc. - biphasic isophane human insulin (rdna) , isophane suspension , soluble insulin - suspension for injection (im / sc) - 100iu/ml - anti-diabetic - for the treatment of diabetes mellitus type i; diabetes mellitus type ii either alone or in combination with oral anti-diabetic agents; emergency management of diabetic ketoacidosis; adult patients with diabetes mellitus for the control of hyperglycemia should be used in regimens that include a longer-acting insulin.

Australia - English - Department of Health (Therapeutic Goods Administration)

novo nordisk pharmaceuticals pty ltd - insulin, quantity: 100 iu/ml - injection, suspension - excipient ingredients: dibasic sodium phosphate dihydrate; sodium hydroxide; zinc chloride; phenol; hydrochloric acid; glycerol; water for injections; protamine sulfate; metacresol - the treatment of insulin-requiring diabetes.

Australia - English - Department of Health (Therapeutic Goods Administration)

novo nordisk pharmaceuticals pty ltd - insulin, quantity: 100 iu/ml - injection, suspension - excipient ingredients: dibasic sodium phosphate dihydrate; phenol; hydrochloric acid; water for injections; metacresol; zinc chloride; protamine sulfate; sodium hydroxide; glycerol - the treatment of insulin-requiring diabetes.

Australia - English - Department of Health (Therapeutic Goods Administration)

novo nordisk pharmaceuticals pty ltd - insulin, quantity: 100 iu/ml - injection, suspension - excipient ingredients: hydrochloric acid; zinc chloride; protamine sulfate; sodium hydroxide; metacresol; dibasic sodium phosphate dihydrate; water for injections; glycerol; phenol - the treatment of insulin-requiring diabetes.

Australia - English - Department of Health (Therapeutic Goods Administration)

novo nordisk pharmaceuticals pty ltd - insulin, quantity: 50 iu/ml - injection, suspension - excipient ingredients: dibasic sodium phosphate dihydrate; glycerol; metacresol; hydrochloric acid; zinc chloride; sodium hydroxide; phenol; water for injections; protamine sulfate - the treatment of insulin-requiring diabetes.